Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
AbstractAbstract
Open Access

In this issueREVIEW ARTICLEORIGINAL ARTICLES

Saudi Medical Journal July 2015, 36 (7) 783;
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

REVIEW ARTICLE

The role of microRNAs in regulating myocardial ischemia reperfusion injury

This review by Fan and Yang summarizes the latest insights on the role of specific microRNAs (miRNAs) in myocardial ischemia reperfusion (I/R) injury, and the data indicates that the roles of different miRNAs are much different in this process. Briefly, miRNAs including miRNA-126, miRNA-133, miRNA-144, miRNA-145, miRNA-199a, miRNA-210, miRNA-214, miRNA-494, miRNA-451, miRNA-499 are protective after myocardial I/R injury. While the miRNAs including miRNA-1, miRNA-15, miRNA-92a, miRNA-320 have opposite effects. Complexly, some other miRNAs such as miRNA-21, miRNA-24, miRNA-29 have a double-edged role. Modulation of miRNA levels directly, or indirectly provides a therapeutic advantage to interfere with myocardial I/R injury.

see page 787

ORIGINAL ARTICLES

Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia

The hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections is still very common among heroin injectors in Saudi Arabia, just like in Western countries. Alshomrani carried out a retrospective data analysis of all heroin addicts admitted to the Alamal Complex for Mental Health in Riyadh, Saudi Arabia between 2006 and 2012. His study showed a prevalence of 77.8% for HCV, 7.7% for HBV, and 9.8% for HIV infection. In comparison with actual prevalence of these infections among the general Saudi population, this high prevalence indicates a major public health concern. Infection control strategies such as, harm reduction, opioid substitution therapy, patients and staff education, and providing infection treatment services at such centers should be reconsidered.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Frequency of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections among 378 Saudi heroin users by different age group

see page 802

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

The adverse drug reactions reporting information in the Saudi Adverse Event Reporting System (SAERS) needs to be assessed to evaluate the completeness and quality of the information. In this study, Alshammari et al start assessing the SAERS database, which is part of the Saudi Food and Drug authority vigilance system as post marketing surveillance. Reports received between December 2009 and June 2012 were all included in the SAERS for the purpose of this evaluation. As the main finding, the SAERS is relatively considered a new system, despite that; it has a high number of reports. However, there is a need to improve the completeness of some important fields to help in discovering new signals.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

The total report section completeness percentages of the information detailed in reporting forms during the study period. ADR - adverse drug reactions

see page 821

Chronic renal failure in a patient with bilateral ureterocele

Chronic renal failure is a rare complication of bilateral ureterocele. Early detection of the abnormalities and adequate treatment may prevent development of irreversible renal failure. Dada et al report a case of a young Nigerian girl with bilateral ureterocele who presented with chronic renal failure that required renal replacement therapy, and features of type III pseudohypoaldosteronism. Her management was inadequate due to financial and resource constraints. The case underscores the need for proper evaluation and follow-up of patients with childhood clinical features of ureterocele to prevent future complications. It also illustrated the financial burden of patients with chronic renal failure in Africa.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Ultrasound showing: A) dilated cystic distal portion of the ureters; and B) opening into the urinary bladder. Arrowheads indicating ureteroceles

see page 862

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (7)
Saudi Medical Journal
Vol. 36, Issue 7
1 Jul 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In this issueREVIEW ARTICLEORIGINAL ARTICLES
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
In this issueREVIEW ARTICLEORIGINAL ARTICLES
Saudi Medical Journal Jul 2015, 36 (7) 783;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In this issueREVIEW ARTICLEORIGINAL ARTICLES
Saudi Medical Journal Jul 2015, 36 (7) 783;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In this issueSystematic ReviewOriginal ArticlesCase Report
  • In this issueSystematic ReviewOriginal Articles
  • In this issueClinical GuidelinesOriginal Articles
Show more Abstract

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire